Parallax Volatility Advisers, L.P. Seres Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $163,680 - $378,400	176,000 New	176,000 $246,000
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $1,050 - $2,160	300 New	300 $2,000
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $151,704 - $288,036	-25,200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $2,408 - $4,572	-400 Reduced 1.56%	25,200 $210,000
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $139,776 - $578,560	25,600 New	25,600 $177,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.